[citation needed] Since 1985, Collins has been co-director with Sir Richard Peto of the University of Oxford's Clinical Trial Services and Epidemiological Studies units.
Since September 2005, he has also been acting as the Principal Investigator and Chief Executive of the UK Biobank,[3][4][5] a prospective study of 500,000 British people, aged 40–69 at recruitment.
[9] He has created and led large studies that transformed statins from esoteric drugs for familial hypercholesterolaemia into widely-used generics that prevent millions of heart attacks and ischaemic strokes annually.
[12] "All text published under the heading 'Biography' on Fellow profile pages is available under Creative Commons Attribution 4.0 International License.” --"Royal Society Terms, conditions and policies".
{{cite web}}: CS1 maint: bot: original URL status unknown (link) This United Kingdom biographical article related to medicine is a stub.